Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant vs Rizatriptan in ED Patients With Migraine Headache
NCT06473597Phase 4Recruiting
- Start
- Sep 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rimegepant in migraine. Started Sep 2024; status: recruiting.
02
Drugs
rimegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06473597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06473597.